Accessibility Tools
POR FESR SARDEGNA 2014 – 2020 ASSE PRIORITARIO 1 “RICERCA SCIENTIFICA, SVILUPPO TECNOLOGICO E INNOVAZIONE” AZIONE 1.1.4
Inizio:
Fine:
The project aims to develop a non-invasive protocol to analyze the genetic profile of ctDNA (circulating tumor DNA) extracted from liquid biopsy of haematological and oncological patients, through the application of next generation sequencing technologies (NGS) on a panel of genes.
NIASMIC, promoted by the regional agency Sardegna Ricerche through the “Cluster top-down actions” program, is financed through the POR FESR of the Autonomous Region of Sardinia 2014-2020
| Nome | Nazione | Ruolo |
|---|---|---|
| Azienda Ospedaliera 'G.Brotzu' | Italy | Partner |
| Yenetics srl | Italy | Partner |
| NUREX srl | Italy | Partner |
| KITOS srl | Italy | Partner |
| BGT-Italia srl | Italy | Partner |
| Chrono-Benessere srl | Italy | Partner |
| Microtec srl | Italy | Partner |
| ARDEA srl | Italy | Partner |
Centro di Ricerca, Sviluppo e Studi Superiori in Sardegna
